project id: TCGA-BRCA; case submitter id: TCGA-BH-A6R9; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 8.2; age at index: 61; days to birth: -22325; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22325; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 160.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8575/3; primary diagnosis: Metaplastic carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 237; initial weight: 220.0; sample id: 65842833-68a7-4efd-a781-19b5dc6bd257; sample submitter id: TCGA-BH-A6R9-01A; portion id: 90b1c42c-1314-41ed-9e26-4dec8a7c603f; portion submitter id: TCGA-BH-A6R9-01A-21; slide id: 2a3b365c-a41a-450b-bb31-798b87d3c423; slide submitter id: TCGA-BH-A6R9-01A-02-TSB; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 10.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;